Active ingredientTolafentrineCat. No. P-T146-001CAS 139308-64-8Family · Pharmaceutical analytical standards
Tolafentrine
A dual inhibitor of phosphodiesterases 3 and 4, studied as a possible medicine for pulmonary hypertension and chronic obstructive pulmonary disease (COPD); its clinical development stopped at phase 2. This family brings together the active ingredient.
Did you know?It shares its mechanism with ensifentrine, approved in the United States in 2024 for COPD: blocking PDE3 widens the airways, while blocking PDE4 dampens inflammation.
Go to the active ingredient →Active ingredientTolafentrineCat. No. P-T146-001CAS 139308-64-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.